Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer interface (BCI).

Paradromics Inc., a brain implant company and rival to Elon Musk’s Neuralink Corp., has gained US approval to begin its first ...

The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

But now, in the age of artificial intelligence, it is increasingly constrained by limitations that cannot adequately meet ...